| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |